Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Investor Alert: Deadline in Lawsuit
A deadline is coming up on December 9, 2013 in the lawsuit filed for investors of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) over alleged seucirities laws violations by Achillion Pharmaceuticals. in connection with certain statements made regarding its investigative drug for the treatment of hepatitis, sovaprevir.
View full press release